Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
29 hedge funds and large institutions have $4.38M invested in Nymox Pharmaceutical Corp in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
91% more capital invested
Capital invested by funds: $2.3M → $4.38M (+$2.08M)
38% more funds holding
Funds holding: 21 → 29 (+8)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
15% more call options, than puts
Call options by funds: $55K | Put options by funds: $48K
0.42% more ownership
Funds ownership: 0.89% → 1.31% (+0.42%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$509K |
| 2 |
Renaissance Technologies
New York
|
+$232K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$149K |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$144K |
| 5 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
+$124K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$286K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$114K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$19.7K |
| 4 |
WP
WMS Partners
Towson,
Maryland
|
-$13.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.73K |
NYMX Hedge Fund Activity: Q3 2013 in Review
29 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2013, worth a combined $4.38M — up 91% from $2.3M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NYMX positions and 1 closed out — a net gain of 8 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Canada Pension Plan Investment Board, opening a new position worth an estimated $509K. The largest seller was Susquehanna International Group, cutting an estimated $286K.
- 29 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2013, up from 21 in Q2 2013.
- Funds reported $4.38M of Nymox Pharmaceutical Corp stock for Q3 2013, up 91% quarter-over-quarter.
- 9 funds opened new Nymox Pharmaceutical Corp positions in Q3 2013 and 1 closed out, a net change of +8 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q3 2013 was Canada Pension Plan Investment Board, an estimated $509K added.
- The largest Nymox Pharmaceutical Corp seller in Q3 2013 was Susquehanna International Group, an estimated $286K sold.
Based on aggregated 13F filings for Q3 2013.